Early clinical phenotypes, clinical staging, and strategic biomarker research: building blocks for personalized psychiatry, Biol. Psychiatry, vol.74, pp.394-395, 2013. ,
The psychosis high-risk state: a comprehensive state-of-the-art review, JAMA Psychiatry, vol.70, pp.107-120, 2013. ,
Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis, Schizophr. Bull, vol.1, issue.1, pp.247-255, 2019. ,
Methylomic changes during conversion to psychosis, Mol. Psychiatry, vol.22, pp.512-518, 2017. ,
14-3-3 proteins in the nervous system, Nat. Rev. Neurosci, vol.4, pp.752-762, 2003. ,
14-3-3 proteins in neurological disorders, Int. J. Biochem. Mol. Biol, vol.3, pp.152-164, 2012. ,
14-3-3 proteins: a historic overview, Semin. Cancer Biol, vol.16, pp.162-172, 2006. ,
Specific acidic proteins of the nervous system, Physiol. Biochem. Asp. Nerv. Integr, pp.343-359, 1967. ,
Isoforms of 14-3-3 protein can form homo-and heterodimers in vivo and in vitro: implications for function as adapter proteins, FEBS Lett, vol.368, pp.55-58, 1995. ,
Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine, Cell, vol.84, pp.889-897, 1996. ,
The structural basis for 14-3-3:phosphopeptide binding specificity, Cell, vol.91, pp.961-971, 1997. ,
14-3-3 Proteins in Brain Development: Neurogenesis, Neuronal Migration and Neuromorphogenesis, Front. Mol. Neurosci, p.10, 2017. ,
Modulation of inactivation properties of CaV2. 2 channels by 14-3-3 proteins, Neuron, vol.51, pp.755-771, 2006. ,
Adapter protein 14-3-3 is required for a presynaptic form of LTP in the cerebellum, Nat. Neurosci, vol.7, pp.1296-1298, 2004. ,
14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome, Nat. Genet, vol.34, pp.274-285, 2003. ,
Brain 14-3-3 protein is an activator protein that activates tryptophan 5-monooxygenase and tyrosine 3-monooxygenase in the presence of Ca2+,calmodulin-dependent protein kinase II, FEBS Lett, vol.219, pp.79-82, 1987. ,
Paradoxical Improvement of Schizophrenic Symptoms by a Dopaminergic Agonist: An Example of Personalized Psychiatry in a Copy Number Variation-Carrying Patient, Biol. Psychiatry, vol.80, pp.21-23, 2016. ,
Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia, Hum. Mol. Genet, vol.17, pp.3212-3222, 2008. ,
An association study between polymorphisms in three genes of 14-3-3 (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein) family and paranoid schizophrenia in northern Chinese population, Eur. Psychiatry J. Assoc. Eur. Psychiatr, vol.19, pp.377-379, 2004. ,
Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1, Am. J. Med. Genet, vol.54, pp.36-43, 1994. ,
14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia, Am. J. Med. Genet, vol.88, pp.164-167, 1999. ,
Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene, Mol. Psychiatry, vol.8, pp.156-166, 2003. ,
Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder, Schizophr. Res, vol.78, pp.137-146, 2005. ,
Implications of Newly Identified Brain eQTL Genes and Their Interactors in Schizophrenia, Mol. Ther. Nucleic Acids, vol.12, pp.433-442, 2018. ,
The neuroproteomics of schizophrenia, Biol. Psychiatry, vol.69, pp.163-172, 2011. ,
Psychiatric disorders biochemical pathways unraveled by human brain proteomics, Eur. Arch. Psychiatry Clin. Neurosci, vol.267, pp.3-17, 2017. ,
Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with, Schizophrenia. Sci. Rep, vol.6, p.23791, 2016. ,
2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease, Proteomics, vol.9, pp.3368-3382, 2009. ,
Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study, Aust. N. Z. J. Psychiatry, vol.43, pp.310-322, 2009. ,
Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia, Proteomics, vol.8, pp.5097-5107, 2008. ,
Up-regulated 14-3-3? and 14-3-3? proteins in prefrontal cortex of subjects with schizophrenia: effect of psychotropic treatment, Schizophr. Res, vol.161, pp.446-451, 2015. ,
Overexpression of the 14-3-3gamma protein in embryonic mice results in neuronal migration delay in the developing cerebral cortex, Neurosci. Lett, vol.628, pp.40-46, 2016. ,
Regulation of neuronal morphogenesis by 14-3-3epsilon (Ywhae) via the microtubule binding protein, doublecortin. Hum. Mol. Genet, vol.25, pp.4405-4418, 2016. ,
Redox regulation of 14-3-3? controls monocyte migration, Arterioscler. Thromb. Vasc. Biol, vol.34, pp.1514-1521, 2014. ,
Protein kinase Cdelta is associated with 14-3-3 phosphorylation in seizure-induced neuronal death, Epilepsy Res, vol.92, pp.30-40, 2010. ,
Role of glial 14-3-3 gamma protein in autoimmune demyelination, J. Neuroinflammation, vol.12, p.187, 2015. ,
The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions, Oncogene, vol.37, pp.5587-5604, 2018. ,
Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer, Int. J. Biol. Markers, vol.29, pp.208-214, 2014. ,
Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset, Transl. Psychiatry, vol.5, p.601, 2015. ,
Impaired metabolic reactivity to oxidative stress in early psychosis patients, Schizophr. Bull, vol.40, pp.973-983, 2014. ,
Oxidative stress and inflammation in first-episode psychosis: A systematic review and meta-analysis, Schizophr. Bull, vol.45, pp.742-751, 2018. ,
Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?, Schizophr. Res, vol.199, pp.31-38, 2018. ,
High frequency of hypermethylation at the 14-3-3 ? locus leads to gene silencing in breast cancer, Proc. Natl. Acad. Sci, vol.97, pp.6049-6054, 2000. ,
Identification of 14-3-3? Gene as a Novel miR-152 Target Using a Proteome-based Approach, J. Biol. Chem, vol.289, pp.31121-31135, 2014. ,
Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact, Mol. Cell. Proteomics MCP, vol.10, 2011. ,
Copy number gain and oncogenic activity of YWHAZ/14-3-3? in head and neck squamous cell carcinoma, Int. J. Cancer J. Int. Cancer, vol.125, pp.603-611, 2009. ,
Downregulation of 14-3-3? in ovary, prostate and endometrial carcinomas is associated with CpG island methylation, Mod. Pathol, vol.18, pp.340-348, 2005. ,
miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta, Genes Dev, vol.24, pp.1620-1633, 2010. ,
Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia, Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol, vol.30, pp.974-983, 2005. ,
On the outside, looking in: a review and evaluation of the comparability of blood and brain '-omes', Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet, vol.162, pp.595-603, 2013. ,
Neuroprotective function of 14-3-3 proteins in neurodegeneration, BioMed Res. Int, p.564534, 2013. ,
A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord, J. Neurochem, vol.75, pp.2511-2520, 2000. ,
14-3-3 adaptor protein-protein interactions as therapeutic targets for CNS diseases, Pharmacol. Res, vol.125, pp.114-121, 2017. ,
14-3-3 proteins as potential therapeutic targets, Semin. Cell Dev. Biol, vol.22, pp.705-712, 2011. ,
The C'JAAD: a French team for early intervention in psychosis in Paris, Early Interv. Psychiatry, 2016. ,
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States, Aust. N. Z. J. Psychiatry, vol.39, pp.964-971, 2005. ,
,
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial, BMJ, vol.344, p.2233, 2012. ,
Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc, vol.3, pp.1101-1108, 2008. ,
ggplot2: elegant graphics for data analysis, 2016. ,
, Package 'Hmisc' . R Found. Stat. Comput, 2018.
, Package 'corrplot' . Statistician, vol.56, pp.316-324, 2017.
, Visualization of a Correlation Matrix, 2017.
Hmisc: Harrell Miscellaneous, 2020. ,
We are grateful to Bertrand Ducos and Juliette Pouch from the qPCR-HD-Genomic Paris Centre platform for the qPCR. We thank Matthew J. Morgan (MG Science Communications) for the English editing. This work was supported by a grant by the French Government's Agence Nationale pour la Recherche (ANR, 08-MNP-007), by a grant from the French Ministry of Health's Programme Hospitalier de Recherche Clinique (PHRC, AOM-07-118), and by the grant ANR-13-SAMA-0010 (SAMENTA 2013 -Projet CERBAIS). This work is supported by the French Government, managed by the Agence Nationale de la Recherche (ANR) under the programme "Investissements d'Avenir" with the reference ANR-18-RHUS-0014. The Centre Hospitalier Sainte-Anne sponsored the ICAAR study, Additional financial support was obtained from the Institut National de la Santé et de la Recherche Médicale (INSERM), and Université Paris Descartes, vol.25, p.9863, 2008. ,
, The sponsors had no role in the design and conduct of the study, in the collection, management, analysis or interpretation of the data, Boris Chaumette receives a grant from the Fondation Bettencourt-Schueller. Fanny Demars and Anton Iftimovici receive a funding from the Fondation pour la Recherche Médicale (FRM)